GAO Examines How US Learned To Use Defense Production Act More Effectively Against COVID-19
Executive Summary
Report says agencies took steps to use DPA more effectively, but HHS still working on a strategy for DPA use that will strengthen domestic supply chains and manufacturing.
You may also be interested in...
Biden Launches Effort To Strengthen US Pharmaceutical Supply Chain
Executive order calls for short-term and long-term study, broad consultation, coordination with allies.
As Other US Agencies Respond To The Pandemic, FEMA Fine-Tunes Plan Of Action
Industry wonders how emergency agency's COVID-19 public-private partnerships will fit in with the others.
FDA Email Alert: Next Day’s Manufacturing Volume Reporting Due Date Still Voluntary
Objections to 15 February reporting date established in draft guidance spurred rare last-minute notice assuring industry that it was a non-binding recommendation, not a requirement. Action reflects confusion that can arise in interpreting policy guidance.